Brief: Ideaya Biosciences Announces Clearance For IDE034
01/12/2025 11:33
Dec 1 (Reuters) - IDEAYA Biosciences Inc IDYA.O: IDEAYA BIOSCIENCES ANNOUNCES IND CLEARANCE FOR IDE034, A POTENTIAL FIRST-IN-CLASS BISPECIFIC B7H3/PTK7 TOP1 ADC TARGETING MULTIPLE SOLID TUMOR TYPES IDEAYA BIOSCIENCES INC - TO BEGIN ENROLLING STUDY IN Q1 2026 Source text: ID:nPn6CGX5a Further company coverage: IDYA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on IDEAYA Biosciences
See all newsBrief: Ideaya Biosciences And Servier Announce Data From Three Clinical Trials At Esmo 2026 Supporting The Potential Of Darovasertib To Become A Foundational New Therapy For Patients Across The Treatment Journey Of Uveal Melanoma
Brief: Ideaya Biosciences Announces The Promotion Of Dr. Michael White To President, Research And Development
Brief: Ideaya Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Ideaya Biosciences Inc Reports Results For The Quarter Ended June 30: Earnings Summary
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj